Live attenuated AIDS viruses as vaccines: promise or peril?
about
Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionCharacterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China.Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsNovel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequencesCD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virusCoreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.Envelope determinants of equine lentiviral vaccine protection.DNA vaccines: ready for prime time?Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccineThe roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses.New paradigms for HIV/AIDS vaccine development.Even attenuated bovine leukemia virus proviruses can be pathogenic in sheepAbrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.Intranasal delivery of vaccines against HIV.A new era in HIV vaccine development.Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.Delivery strategies for novel vaccine formulations.Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirusSynthetic biology approach for the development of conditionally replicating HIV-1 vaccine.Immunity and protection by live attenuated HIV/SIV vaccines.HIV-1 Gag-virus-like particles induce natural killer cell immune responses via activation and maturation of dendritic cells.Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections.
P2860
Q26775082-F1D580DD-65DA-4EF9-A1F7-F92E64C3D40EQ33827432-DCF4920A-DFC4-4FB3-85E0-2AB8F7245C8EQ33839136-BFCADB9A-7DC5-43A8-9C29-1D190DFA9A05Q33852720-0F3C44D2-3DFC-4A46-A8FE-342EB8A8D833Q33865700-FC05EE1F-B770-43C1-B746-6D251C036262Q33984208-D115F704-990B-40E9-9EC4-A56A2B6B1551Q34342429-D2AE0D14-6099-4F79-809E-C3577314BF1DQ34778836-C34C8152-3C0A-4717-9E15-FE4993FFD99FQ34824179-95AE0CB4-06F9-40C5-B412-C0A206D5775CQ35709133-A52A9402-54DE-44CC-AA8F-A7F4DE453116Q35851774-1E08320C-6595-46C3-A7C1-EC4F9C56ACBCQ35851778-CA83B634-C5AF-4932-BA20-9551CA667E96Q36011269-F0947E73-2F6E-4313-8D9F-E1104C00AC69Q36098921-BBBBFD32-7DD9-4DE9-9C03-264C3330F764Q36105943-735056B5-E0AB-4A4C-B4C2-F78D6D53AD1AQ36154801-44F2D1FE-042C-4BF1-988B-1C98C84900AAQ36409054-EF1B316D-6196-4415-9D63-46F637303D01Q36777835-1E4B4951-984E-4564-A75F-42FF45786A71Q36954239-19853D73-B6AE-4ECB-B86F-9BFCC6D03D8FQ37195521-50D6BCF4-4396-4BA1-8A43-EDE82629AE2BQ37368482-72B94DD5-34DF-4D28-BA9E-670A9B944344Q41923238-2CD381A2-2DBE-4A66-9430-7793EC48C2A9Q43213534-22C82610-DF02-4996-A94B-54016A2593E8Q45364806-75A73AF4-A86F-42A1-B0F8-66C10347924EQ55379440-B396CBE9-1C6E-4659-B2AD-FEB19B4EA97A
P2860
Live attenuated AIDS viruses as vaccines: promise or peril?
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Live attenuated AIDS viruses as vaccines: promise or peril?
@ast
Live attenuated AIDS viruses as vaccines: promise or peril?
@en
type
label
Live attenuated AIDS viruses as vaccines: promise or peril?
@ast
Live attenuated AIDS viruses as vaccines: promise or peril?
@en
prefLabel
Live attenuated AIDS viruses as vaccines: promise or peril?
@ast
Live attenuated AIDS viruses as vaccines: promise or peril?
@en
P2860
P1476
Live attenuated AIDS viruses as vaccines: promise or peril?
@en
P2093
Ruprecht RM
P2860
P304
P356
10.1111/J.1600-065X.1999.TB01335.X
P577
1999-08-01T00:00:00Z